A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)
Clinical trial NCT03193190 · COMPLETED
Trial details
- NCT number
- NCT03193190
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2025-02-27
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.